Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy

Acta Biomaterialia

Volumn 38, Issue , 2016, Pages 69-81

  Banerjee, Indranil ^a   De, Kakali ^a   Mukherjee, Dibyanti ^a   Dey, Goutam ^b   Chattopadhyay, Sankha ^c   Mukherjee, Manabendra ^d   Mandal, Mahitosh ^b   Bandyopadhyay, Amal Kumar ^e   Gupta, Amit ^f   Ganguly, Santanu ^f   Misra, Mridula ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY   (India)

^c VARIABLE ENERGY CYCLOTRON CENTRE   (India)

^d SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

^e JADAVPUR UNIVERSITY   (India)

^f Regional Radiation Medicine Centre Thakurpukur Cancer Research Centre   (India)

Author keywords

Dual targeting; Glioma therapy; Paclitaxel; Solid lipid nanoparticles; Tyr 3 octreotide

Indexed keywords

CELL DEATH; CHEMOTHERAPY; DISEASES; EFFICIENCY; ENDOTHELIAL CELLS; MAMMALS; NANOPARTICLES; SYNTHESIS (CHEMICAL);

DUAL-TARGETING; GLIOMA CELLS; GLIOMA THERAPY; LIPID NANOPARTICLES; NEOVASCULATURE; OCTREOTIDE; PACLITAXEL; SOLID LIPID NANOPARTICLE; SOMATOSTATIN RECEPTORS; TYR-3-OCTREOTIDE;

TUMORS;

1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; CD31 ANTIGEN; GLYCEROPHOSPHOETHANOLAMINE; MACROGOL; OCTREOTIDE[3 TYROSINE]; PACLITAXEL; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; 3-TYR-OCTREOTIDE; DRUG CARRIER; LIPID; NANOPARTICLE; OCTREOTIDE;

ADULT; ANGIOGENESIS ASSAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC THERAPY; APOPTOSIS; ARTICLE; C6 CELL LINE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RELEASE; DRUG STABILITY; DRUG TARGETING; FEMALE; GLIOMA; GLIOMA CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; METRONOMIC DRUG ADMINISTRATION; NANOPHARMACEUTICS; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; METABOLISM; MOUSE; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELL LINE; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; CELL LINE, TUMOR; DRUG CARRIERS; GLIOMA; LIPIDS; MICE; NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; OCTREOTIDE; PACLITAXEL; RATS;

EID: 84966681496     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2016.04.026     Document Type: Article

References (35)

1. Q. Hu, X. Gao, G. Gu, T. Kang, Y. Tu, Z. Liu, Q. Song, L. Yao, Z. Pang, X. Jiang, H. Chen, and J. Chen Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel Biomaterials 34 2013 5640 5650
2. P. Blasi, S. Giovagnoli, A. Schoubben, M. Ricci, and C. Rossi Solid lipid nanoparticles for targeted brain drug delivery Adv. Drug Deliv. Rev. 59 2007 454 477
3. J.M. Koziara, P.R. Lockman, D.D. Allen, and R.J. Mumper Paclitaxel nanoparticles for the potential treatment of brain tumors J. Control. Release 99 2004 259 269
4. S. Sharma, A. Verma, G. Pandey, N. Mittapelly, and P.R. Mishra Investigating the role of Pluronic-g-Cationic polyelectrolyte as functional stabilizer for nanocrystals: Impact on Paclitaxel oral bioavailability and tumor growth Acta Biomater. 26 2015 169 183
5. http://www.cancer.gov/about-cancer/treatment/drugs/fda-nanoparticle-paclitaxel. Accessed on 23/10/15.
6. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
7. G. Gu, Q. Hu, X. Feng, X. Gao, J. Menglin, T. Kang, D. Jiang, Q. Song, H. Chen, and J. Chen PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy Biomaterials 35 2014 8215 8226
8. J. Held-Feindt, B. Krisch, and R. Mentlein Molecular analysis of the somatostatin receptor subtype 2 in human glioma cells Brain Res. Mol. Brain Res. 64 1999 101 107
9. P. Cervera, C. Videau, C. Viollet, C. Petrucci, J. Lacombe, R. Winsky-Sommerer, Z. Csaba, L. Helboe, C. Daumas-Duport, J.C. Reubi, and J. Epelbaum Comparison of somatostatin receptor expression in human gliomas and medulloblastomas J. Neuroendocrinol. 14 2002 458 471
10. J. Zhang, W. Jin, X. Wang, J. Wang, X. Zhang, and Q. Zhang A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models Mol. Pharm. 7 2010 1159 1168
11. A. Helbok, C. Rangger, E. von Guggenberg, M. Saba-Lepek, T. Radolf, G. Thurner, F. Andreae, R. Prassl, and C. Decristoforo Targeting properties of peptide-modified radiolabeled liposomal nanoparticles Nanomedicine 8 2012 112 118
12. J.S. Lewis, M.R. Lewis, A. Srinivasan, M.A. Schmidt, J. Wang, and C.J. Anderson Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy J. Med. Chem. 42 1999 1341 1347
13. K. De, A. Bhowmik, A. Behera, I. Banerjee, M.K. Ghosh, and M. Misra Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy J. Pept. Sci. 18 2012 720 730
14. K. De, I. Banerjee, and M. Misra Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation Amino Acids 47 2015 1135 1153
15. N. Zhang, Q. Ping, G. Huang, W. Xu, Y. Cheng, and X. Han Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin Int. J. Pharm. 327 2006 153 159
16. I. Banerjee, K. De, S. Chattopadhyay, A.K. Bandyopadhyay, and M. Misra An easy and effective method for radiolabelling of solid lipid nanoparticles J. Radioanal. Nucl. Chem. 302 2014 837 843
17. P. Venkatesan, N. Puvvada, R. Dash, B.N. Prashanth Kumar, D. Sarkar, B. Azab, A. Pathak, S.C. Kundu, P.B. Fisher, and M. Mandal The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer Biomaterials 32 2011 3794 3806
18. X. Ying, H. Wen, W.L. Lu, J. Du, J. Guo, W. Tian, Y. Men, Y. Zhang, R.J. Li, T.Y. Yang, D.W. Shang, J.N. Lou, L.R. Zhang, and Q. Zhang Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals J. Control. Release 141 2010 183 192
19. 99mTc-paclitaxel: a potential tracer of paclitaxel J. Radioanal. Nucl. Chem. 304 2015 633 643
20. 99mTc: preparation, physicochemical characterization, biodistribution study, and scintigraphic imaging in Swiss mice Int. J. Pharm. 423 2012 489 495
21. S.S. Ng, A. Sparreboom, Y. Shaked, C. Lee, S. Man, N. Desai, P. Soon-Shiong, W.D. Figg, and R.S. Kerbel Influence of formulation vehicle on metronomic taxane chemotherapy: albumin-bound versus cremophor EL-based paclitaxel Clin. Cancer Res. 12 2006 4331 4338
22. S. Agarwal, R. Sane, R. Oberoi, J.R. Ohlfest, and W.F. Elmquist Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain Expert Rev. Mol. Med. 13 2011
23. A. Merlo, O. Hausmann, M. Wasner, P. Steiner, A. Otte, E. Jermann, P. Freitag, J.C. Reubi, J. Müller-Brand, O. Gratzl, and H.R. Mäcke Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas Clin. Cancer Res. 5 1999 1025 1033
24. D. Belotti, V. Vergani, T. Drudis, P. Borsotti, M.R. Pitelli, G. Viale, R. Giavazzi, and G. Taraboletti The microtubule-affecting drug paclitaxel has antiangiogenic activity Clin. Cancer Res. 2 1996 1843 1849
25. M. Pàez-Ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Viñals, M. Inoue, G. Bergers, D. Hanahan, and O. Casanovas Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell 15 2009 220 231
26. R. Maji, N.S. Dey, B.S. Satapathy, B. Mukherjee, and S. Mondal Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy Int. J. Nanomed. 9 2014 3107 3118
27. D.B. Reardon, S.L. Wood, D.L. Brautigan, G.I. Bell, P. Dent, and T.W. Sturgill Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin Biochem. J. 314 1996 401 404
28. J.C. Watson, D.A. Balster, B.M. Gebhardt, T.M. O'Dorisio, M.S. O'Dorisio, G.D. Espenan, G.J. Drouant, and E.A. Woltering Growing vascular endothelial cells express somatostatin subtype 2 receptors Br. J. Cancer 85 2001 266 272
29. S. Valetti, S. Mura, M. Noiray, S. Arpicco, F. Dosio, J. Vergnaud, D. Desmaële, B. Stella, and P. Couvreur Peptide conjugation: before or after nanoparticle formation? Bioconjugate Chem. 25 2014 1971 1983
30. S.C. Yang, L.F. Lu, Y. Cai, J.B. Zhu, B.W. Liang, and C.Z. Yang Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain J. Control. Release 59 1999 299 307
31. S. Gelperina, O. Maksimenko, A. Khalansky, L. Vanchugova, E. Shipulo, K. Abbasova, R. Berdiev, S. Wohlfart, N. Chepurnova, and J. Kreuter Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters Eur. J. Pharm. Biopharm. 74 2010 157 163
32. X. Ma, H. Wang, S. Jin, Y. Wu, and X.J. Liang Construction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)- 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity Int. J. Nanomed. 7 2012 1313 1328
33. Y. Liu, Y.C. Tseng, and L. Huang Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method? Pharm. Res. 29 2012 3273 3277
34. V.P. Torchilin Multifunctional nanocarriers Adv. Drug Deliv. Rev. 58 2006 1532 1555
35. A.B. Etame, C.A. Smith, W.C. Chan, and J.T. Rutka Design and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculature Nanomedicine 7 2011 992 1000